Human	B-protein
immunodeficiency	I-protein
virus	I-protein
type	I-protein
1	I-protein
Nef	I-protein
protein	I-protein
inhibits	O
NF-kappa	B-protein
B	I-protein
induction	O
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
can	O
establish	O
a	O
persistent	O
and	O
latent	O
infection	O
in	O
CD4+	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
(	O
W.C.Greene	O
,	O
N.Engl.J.	O
Med.324	O
:	O
308-317	O
,	O
1991	O
;	O
S.M.Schnittman	O
,	O
M.C.Psallidopoulos	O
,	O
H.C.	O
Lane	O
,	O
L.Thompson	O
,	O
M.Baseler	O
,	O
F.Massari	O
,	O
C.H.Fox	O
,	O
N.P.Salzman	O
,	O
and	O
A.S.Fauci	O
,	O
Science	O
245	O
:	O
305-308	O
,	O
1989	O
)	O
.	O

Production	O
of	O
HIV-1	O
from	O
latently	O
infected	O
cells	O
requires	O
host	O
cell	O
activation	O
by	O
T-cell	B-protein
mitogens	I-protein
(	O
T.Folks	O
,	O
D.M.Powell	O
,	O
M.M.Lightfoote	O
,	O
S.Benn	O
,	O
M.A.	O
Martin	O
,	O
and	O
A.S.Fauci	O
,	O
Science	O
231	O
:	O
600-602	O
,	O
1986	O
;	O
D.Zagury	O
,	O
J.	O
Bernard	O
,	O
R.Leonard	O
,	O
R.Cheynier	O
,	O
M.Feldman	O
,	O
P.S.Sarin	O
,	O
and	O
R.C.	O
Gallo	O
,	O
Science	O
231	O
:	O
850-853	O
,	O
1986	O
)	O
.	O

This	O
activation	O
is	O
mediated	O
by	O
the	O
host	B-protein
transcription	I-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
[	O
G.Nabel	O
and	O
D.Baltimore	O
,	O
Nature	O
(	O
London	O
)	O
326	O
:	O
711-717	O
,	O
1987	O
]	O
.	O

We	O
report	O
here	O
that	O
the	O
HIV-1-encoded	B-protein
Nef	I-protein
protein	I-protein
inhibits	O
the	O
induction	O
of	O
NF-kappa	B-protein
B	I-protein
DNA-binding	O
activity	O
by	O
T-	B-protein
cell	I-protein
mitogens	I-protein
.	O

However	O
,	O
Nef	B-protein
does	O
not	O
affect	O
the	O
DNA-binding	O
activity	O
of	O
other	O
transcription	B-protein
factors	I-protein
implicated	O
in	O
HIV-1	O
regulation	O
,	O
including	O
SP-1	B-protein
,	O
USF	B-protein
,	O
URS	B-protein
,	O
and	O
NF-AT	B-protein
.	O

Additionally	O
,	O
Nef	B-protein
inhibits	O
the	O
induction	O
of	O
HIV-1-	O
and	O
interleukin	O
2-directed	O
gene	O
expression	O
,	O
and	O
the	O
effect	O
on	O
HIV-1	O
transcription	O
depends	O
on	O
an	O
intact	O
NF-kappa	B-DNA
B-binding	I-DNA
site	I-DNA
.	O

These	O
results	O
indicate	O
that	O
defective	O
recruitment	O
of	O
NF-kappa	B-protein
B	I-protein
may	O
underlie	O
Nef	B-protein
's	O
negative	O
transcriptional	O
effects	O
on	O
the	O
HIV-1	B-DNA
and	I-DNA
interleukin	I-DNA
2	I-DNA
promoters	I-DNA
.	O

Further	O
evidence	O
suggests	O
that	O
Nef	B-protein
inhibits	O
NF-kappa	B-protein
B	I-protein
induction	O
by	O
interfering	O
with	O
a	O
signal	O
derived	O
from	O
the	O
T-cell	B-protein
receptor	I-protein
complex	I-protein
.	O

JOURNAL	NULL
or	NULL
Virorocy	NULL
,	NULL
Oct.	NULL
1992	NULL
,	NULL
p.	NULL
6213-6219	NULL
0022-538	NULL
X/92/106213-07	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1992	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

66	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Nef	NULL
Protein	NULL
Inhibits	NULL
NF-KB	NULL
Induction	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
THOMAS	NULL
M.	NULL
J.	NULL
NIEDERMAN	NULL
,	NULL
'	NULL
J.	NULL
VICTOR	NULL
GARCIA	NULL
,	NULL
``	NULL
W.	NULL
RANDALL	NULL
HASTINGS	NULL
,	NULL
``	NULL
SYLVIE	NULL
LURIA	NULL
,	NULL
``	NULL
anp	NULL
LEE	NULL
RATNER'*	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Molecular	NULL
Microbiology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
;	NULL
Department	NULL
of	NULL
Virolo	NULL
%	NULL
y	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Saint	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
Tennessee	NULL
38101	NULL
``	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Beckman	NULL
Center	NULL
,	NULL
Stanford	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305	NULL
Received	NULL
30	NULL
April	NULL
1992/Accepted	NULL
21	NULL
July	NULL
1992	NULL
Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
can	NULL
establish	NULL
a	NULL
persistent	NULL
and	NULL
latent	NULL
infection	NULL
in	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
(	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

324:308-317	NULL
,	NULL
1991	NULL
;	NULL
S.	NULL
M.	NULL
Schnittman	NULL
,	NULL
M.	NULL
C.	NULL
Psallidopoulos	NULL
,	NULL
H.	NULL
C.	NULL
Lane	NULL
,	NULL
L.	NULL
Thompson	NULL
,	NULL
M.	NULL
Baseler	NULL
,	NULL
F.	NULL
Massari	NULL
,	NULL
C.	NULL
H.	NULL
Fox	NULL
,	NULL
N.	NULL
P.	NULL
Salzman	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
Science	NULL
245:305-308	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

Production	NULL
of	NULL
HIV-1	NULL
from	NULL
latently	NULL
infected	NULL
cells	NULL
requires	NULL
host	NULL
cell	NULL
activation	NULL
by	NULL
T-cell	NULL
mitogens	NULL
(	NULL
T.	NULL
Folks	NULL
,	NULL
D.	NULL
M.	NULL
Powell	NULL
,	NULL
M.	NULL
M.	NULL
Lightfoote	NULL
,	NULL
S.	NULL
Benn	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
Science	NULL
231:600-602	NULL
,	NULL
1986	NULL
;	NULL
D.	NULL
Zagury	NULL
,	NULL
J.	NULL
Bernard	NULL
,	NULL
R.	NULL
Leonard	NULL
,	NULL
R.	NULL
Cheynier	NULL
,	NULL
M.	NULL
Feldman	NULL
,	NULL
P.	NULL
S.	NULL
Sarin	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
Science	NULL
231:850-853	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

This	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
host	NULL
transcription	NULL
factor	NULL
NF-B	NULL
[	NULL
G.	NULL
Nabel	NULL
and	NULL
D.	NULL
Baltimore	NULL
,	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-717	NULL
,	NULL
1987	NULL
]	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
HIV-l-encoded	NULL
Nef	NULL
protein	NULL
inhibits	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
by	NULL
T-cell	NULL
mitogens	NULL
.	NULL

However	NULL
,	NULL
Nef	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
implicated	NULL
in	NULL
HIV-1	NULL
regulation	NULL
,	NULL
including	NULL
SP-1	NULL
,	NULL
USF	NULL
,	NULL
URS	NULL
,	NULL
and	NULL
NF-AT	NULL
.	NULL

Additionally	NULL
,	NULL
Nef	NULL
inhibits	NULL
the	NULL
induction	NULL
of	NULL
HIV-1-	NULL
and	NULL
interleukin	NULL
2-directed	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
on	NULL
HIV-1	NULL
transcription	NULL
depends	NULL
on	NULL
an	NULL
intact	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
defective	NULL
recruitment	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
underlie	NULL
Nef	NULL
's	NULL
negative	NULL
transcriptional	NULL
effects	NULL
on	NULL
the	NULL
HIV-1	NULL
and	NULL
interleukin	NULL
2	NULL
promoters	NULL
.	NULL

Further	NULL
evidence	NULL
suggests	NULL
that	NULL
Nef	NULL
inhibits	NULL
NF-B	NULL
induction	NULL
by	NULL
interfering	NULL
with	NULL
a	NULL
signal	NULL
derived	NULL
from	NULL
the	NULL
T-cell	NULL
receptor	NULL
complex	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
can	NULL
establish	NULL
a	NULL
latent	NULL
infection	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Production	NULL
of	NULL
HIV-1	NULL
from	NULL
latently	NULL
infected	NULL
cells	NULL
requires	NULL
host	NULL
cell	NULL
stimulation	NULL
by	NULL
T-cell	NULL
mitogens	NULL
(	NULL
9	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
T-cell-specific	NULL
stimuli	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
antigen	NULL
or	NULL
antibody	NULL
to	NULL
CD2	NULL
or	NULL
CD3	NULL
)	NULL
or	NULL
nonspecific	NULL
mitogens	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
phytohemagglutinin	NULL
[	NULL
PHA	NULL
]	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
[	NULL
PMA	NULL
]	NULL
)	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
host	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
of	NULL
proteins	NULL
normally	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
and	NULL
proliferation	NULL
,	NULL
such	NULL
as	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
the	NULL
alpha	NULL
subunit	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
HIV-1	NULL
promoter	NULL
possesses	NULL
two	NULL
adjacent	NULL
NF-	NULL
«	NULL
xB-binding	NULL
sites	NULL
which	NULL
allow	NULL
the	NULL
virus	NULL
to	NULL
subvert	NULL
the	NULL
normal	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
enhance	NULL
its	NULL
own	NULL
replication	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Previous	NULL
work	NULL
suggests	NULL
that	NULL
the	NULL
HIV-l-encoded	NULL
Nef	NULL
protein	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
HIV-1	NULL
replication	NULL
(	NULL
1	NULL
,	NULL
7	NULL
,	NULL
20	NULL
,	NULL
25	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
found	NULL
that	NULL
Nef	NULL
may	NULL
suppress	NULL
both	NULL
HIV-1	NULL
and	NULL
IL-2	NULL
transcription	NULL
(	NULL
1	NULL
,	NULL
21	NULL
,	NULL
25	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
Nef	NULL
affects	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
or	NULL
other	NULL
transcription	NULL
factors	NULL
implicated	NULL
in	NULL
HIV-1	NULL
regulation	NULL
,	NULL
we	NULL
used	NULL
human	NULL
T-cell	NULL
lines	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
nef	NULL
gene	NULL
.	NULL

Jurkat	NULL
(	NULL
J25	NULL
)	NULL
human	NULL
T-cell	NULL
clone	NULL
133	NULL
constitutively	NULL
expresses	NULL
the	NULL
NL43	NULL
nef	NULL
gene	NULL
.	NULL

22F6	NULL
cells	NULL
represent	NULL
another	NULL
antibiotic-resistant	NULL
clone	NULL
of	NULL
J25	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
these	NULL
cells	NULL
do	NULL
not	NULL
contain	NULL
nef	NULL
sequences	NULL
and	NULL
do	NULL
not	NULL
express	NULL
Nef	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
used	NULL
oligoclonal	NULL
Jurkat	NULL
E6-1	NULL
and	NULL
HPB-ALL	NULL
cells	NULL
expressing	NULL
the	NULL
SF2	NULL
nef	NULL
gene	NULL
either	NULL
in	NULL
the	NULL
correct	NULL
orientation	NULL
(	NULL
Jurkat/LnefSN	NULL
and	NULL
HPB-ALL/	NULL
LnefSNS1	NULL
cells	NULL
)	NULL
or	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
(	NULL
Jurkat/	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

6213	NULL
LfenSN	NULL
and	NULL
HPB-ALL/LfenSN	NULL
cells	NULL
)	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
promoter	NULL
(	NULL
10	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
represent	NULL
a	NULL
mixed	NULL
population	NULL
of	NULL
cells	NULL
expressing	NULL
Nef	NULL
to	NULL
various	NULL
degrees	NULL
and	NULL
were	NULL
used	NULL
to	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
clonal	NULL
selection	NULL
accounts	NULL
for	NULL
Nef	NULL
effects	NULL
observed	NULL
in	NULL
the	NULL
J25	NULL
clones	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
impact	NULL
of	NULL
T-cell	NULL
activation	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
Nef	NULL
,	NULL
the	NULL
human	NULL
T-cell	NULL
lines	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
logarithmic	NULL
growth	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
.	NULL

J25	NULL
and	NULL
Jurkat	NULL
EG-1	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
each	NULL
)	NULL
and	NULL
HPB-ALL	NULL
cells	NULL
(	NULL
1.5	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
either	NULL
not	NULL
stimulated	NULL
or	NULL
stimulated	NULL
with	NULL
13	NULL
mg	NULL
of	NULL
PHA-P	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
75	NULL
ng	NULL
of	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
4	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
rabbit	NULL
anti-Nef	NULL
polyclonal	NULL
serum	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
immunoprecipi-tates	NULL
were	NULL
subjected	NULL
to	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacry	NULL
!	NULL

-amide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
12	NULL
%	NULL
polyacrylamide	NULL
)	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
for	NULL
Western	NULL
immunoblot	NULL
analysis	NULL
.	NULL

The	NULL
primary	NULL
antibody	NULL
was	NULL
the	NULL
rabbit	NULL
anti-Nef	NULL
serum	NULL
,	NULL
and	NULL
the	NULL
secondary	NULL
antibody	NULL
was	NULL
alkaline	NULL
phosphatase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
immunoglobulin	NULL
,	NULL
specific	NULL
for	NULL
the	NULL
heavy	NULL
chain	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
visualized	NULL
by	NULL
color	NULL
development	NULL
with	NULL
nitroblue	NULL
tetra-zolium	NULL
and	NULL
5-bromo-4-chloro-3-indolylphosphate	NULL
toluidin-ium	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Band	NULL
intensity	NULL
was	NULL
determined	NULL
by	NULL
laser	NULL
densitometry	NULL
scanning	NULL
of	NULL
the	NULL
Western	NULL
blot	NULL
and	NULL
was	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
analysis	NULL
as	NULL
established	NULL
by	NULL
a	NULL
standard	NULL
curve	NULL
.	NULL

Jurkat	NULL
E6-1	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
AIDS	NULL
Repository	NULL
,	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Arthur	NULL
Weiss	NULL
)	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
were	NULL
stably	NULL
transduced	NULL
with	NULL
the	NULL
SF2	NULL
nef	NULL
gene	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
with	NULL
anti-Nef	NULL
antibodies	NULL
showed	NULL
that	NULL
6214	NULL
NOTES	NULL
~	NULL
x	NULL
>	NULL
Rs	NULL
&	NULL
&	NULL
&	NULL
5	NULL
ob	NULL
Ao	NULL
Pe	NULL
&	NULL
~é	NULL
>	NULL
>	NULL
«	NULL
o	NULL
C	NULL
G	NULL
Z	NULL
£	NULL
¢	NULL
s	NULL
®	NULL
&	NULL
50	NULL
&	NULL
``	NULL
Y	NULL
~	NULL
>	NULL
J	NULL
»	NULL
x	NULL
,	NULL
»	NULL
\\	NULL
,	NULL
\	NULL
)	NULL
Q	NULL
9	NULL
w	NULL
&	NULL
p	NULL
x*	NULL
x2	NULL
&	NULL
a*	NULL
$	NULL
3	NULL
$	NULL
$	NULL
Ca	NULL
&	NULL
%	NULL
y	NULL
*	NULL
&	NULL
CAAT	NULL
--	NULL
A	NULL
AGT	NULL
stimulation	NULL
.	NULL

-	NULL
+	NULL
so	NULL
,	NULL
40	NULL
Int	NULL
Pik	NULL
luce	NULL
toe	NULL
I	NULL
0	NULL
+	NULL
=	NULL
:	NULL
&	NULL
68	NULL
g	NULL
IgG	NULL
56	NULL
.._	NULL
undo-	NULL
``	NULL
ﬂip	NULL
30	NULL
-	NULL
39	NULL
p	NULL
ms	NULL
-	NULL
Alik	NULL
we	NULL
#	NULL
B	NULL
-	NULL
<	NULL
p27	NULL
21	NULL
14	NULL
6.5	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
the	NULL
HIV-1	NULL
Nef	NULL
protein	NULL
in	NULL
stably	NULL
transfected	NULL
and	NULL
transduced	NULL
human	NULL
T-cell	NULL
lines	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
rabbit	NULL
anti-Nef	NULL
polyclonal	NULL
serum	NULL
,	NULL
electro-phoresed	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
same	NULL
anti-Nef	NULL
serum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
before	NULL
cell	NULL
harvesting	NULL
.	NULL

Pres-tained	NULL
protein	NULL
size	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
in	NULL
kilodaltons	NULL
.	NULL

Nef	NULL
protein	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
was	NULL
expressed	NULL
from	NULL
the	NULL
nef	NULL
gene	NULL
of	NULL
isolate	NULL
pNLA32	NULL
and	NULL
had	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
27	NULL
kDa	NULL
,	NULL
whereas	NULL
the	NULL
Nef	NULL
proteins	NULL
expressed	NULL
in	NULL
the	NULL
Jurkat	NULL
E6-1	NULL
and	NULL
HPB-ALL	NULL
cells	NULL
were	NULL
encoded	NULL
by	NULL
the	NULL
nef	NULL
gene	NULL
of	NULL
isolate	NULL
SF2	NULL
and	NULL
demonstrated	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
29	NULL
kDa	NULL
.	NULL

Immunoglob-ulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
heavy	NULL
chain	NULL
,	NULL
which	NULL
was	NULL
present	NULL
in	NULL
the	NULL
antiserum	NULL
used	NULL
for	NULL
the	NULL
immunoprecipitation	NULL
step	NULL
,	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
right	NULL
.	NULL

stimulation	NULL
caused	NULL
a	NULL
two-	NULL
to	NULL
threefold	NULL
increase	NULL
in	NULL
Nef	NULL
expression	NULL
in	NULL
clone	NULL
133	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
was	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
chimeric	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
-human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
promoter	NULL
used	NULL
to	NULL
direct	NULL
Nef	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
Nef	NULL
expression	NULL
was	NULL
not	NULL
induced	NULL
in	NULL
the	NULL
Jurkat	NULL
E6-1	NULL
or	NULL
HPB-ALL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
Nef	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
comparable	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
Nef	NULL
generated	NULL
by	NULL
HIV-1	NULL
in	NULL
productively	NULL
infected	NULL
CEM	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
the	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
the	NULL
Nef	NULL
produced	NULL
in	NULL
clone	NULL
133	NULL
cells	NULL
and	NULL
those	NULL
produced	NULL
in	NULL
the	NULL
Jurkat/LnefSN	NULL
and	NULL
HPB-ALL/LnefSNS1	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
alanine	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
54	NULL
in	NULL
the	NULL
NLA3	NULL
Nef	NULL
gene	NULL
compared	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
aspartic	NULL
acid	NULL
at	NULL
that	NULL
position	NULL
in	NULL
the	NULL
SF2	NULL
Nef	NULL
gene	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
lysate	NULL
equivalents	NULL
loaded	NULL
in	NULL
the	NULL
HPB-ALL/LnefSNS1	NULL
lanes	NULL
was	NULL
threefold	NULL
larger	NULL
than	NULL
that	NULL
in	NULL
the	NULL
Jurkat/LnefSN	NULL
lanes	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
Nef	NULL
expressed	NULL
in	NULL
the	NULL
HPB-ALL/LnefSNS1	NULL
cells	NULL
was	NULL
approximately	NULL
fourfold	NULL
larger	NULL
than	NULL
the	NULL
amount	NULL
produced	NULL
in	NULL
the	NULL
Jurkat/LnefSN	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Nef	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
toxic	NULL
,	NULL
in	NULL
that	NULL
the	NULL
Nef-producing	NULL
cells	NULL
exhibited	NULL
the	NULL
same	NULL
doubling	NULL
time	NULL
and	NULL
morphology	NULL
as	NULL
the	NULL
control	NULL
cells	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
5	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
with	NULL
a	NULL
modified	NULL
version	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
as	NULL
adapted	NULL
by	NULL
Montminy	NULL
and	NULL
Bilezikjian	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Following	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
,	NULL
nuclear	NULL
proteins	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
a	NULL
solution	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpi-	NULL
J.	NULL
Viror	NULL
.	NULL

perazine-N'-2-ethanesulfonic	NULL
acid	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
17	NULL
%	NULL
glycerol	NULL
(	NULL
33	NULL
)	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
0.1	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
beta-glycerol-phosphate	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
consisted	NULL
of	NULL
the	NULL
supernatant	NULL
resulting	NULL
from	NULL
the	NULL
lysis	NULL
of	NULL
cells	NULL
in	NULL
hypotonic	NULL
lysis	NULL
solution	NULL
,	NULL
Dounce	NULL
homogenization	NULL
,	NULL
and	NULL
low-speed	NULL
centrifugation	NULL
to	NULL
pellet	NULL
nuclei	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
2	NULL
pl	NULL
(	NULL
2	NULL
mg	NULL
)	NULL
of	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
through	NULL
d	NULL
)	NULL
or	NULL
6	NULL
pl	NULL
(	NULL
7	NULL
mg	NULL
)	NULL
of	NULL
cytoplasmic	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

2e	NULL
)	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
ACAACTCACTTTCCGCT	NULL
GCTCACTTTCCAGGGA	NULL
)	NULL
,	NULL
and	NULL
20,000	NULL
cpm	NULL
of	NULL
end-labeled	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
in	NULL
DNA	NULL
binding	NULL
buffer	NULL
(	NULL
27	NULL
)	NULL
,	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
22	NULL
pl	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
at	NULL
30°C	NULL
for	NULL
25	NULL
min	NULL
,	NULL
immediately	NULL
loaded	NULL
on	NULL
a	NULL
4.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
with	NULL
0.5	NULL
x	NULL
Tris-borate-EDTA	NULL
,	NULL
and	NULL
run	NULL
at	NULL
200	NULL
V.	NULL
Oligonucleotides	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
ACAAGGGACTTTCCGC	NULL
TGGGACTTTCCAGGGA	NULL
;	NULL
SP-1	NULL
,	NULL
CAGGGAGGCGTGGCC	NULL
TGGGCGGGACTGGGGAGTGGCGTCC	NULL
.	NULL

All	NULL
DNA	NULL
probes	NULL
were	NULL
gel	NULL
purified	NULL
and	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-°°P	NULL
]	NULL
ATP	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
indicated	NULL
bands	NULL
was	NULL
determined	NULL
by	NULL
laser	NULL
densitometry	NULL
and	NULL
by	NULL
measuring	NULL
the	NULL
radioactivity	NULL
of	NULL
excised	NULL
bands	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

There	NULL
was	NULL
a	NULL
linear	NULL
relationship	NULL
between	NULL
the	NULL
amount	NULL
of	NULL
extract	NULL
used	NULL
and	NULL
DNA-binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
with	NULL
the	NULL
cytoplasmic	NULL
extracts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
deoxycholic	NULL
acid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
with	NULL
the	NULL
Bradford	NULL
reagent	NULL
(	NULL
Bio-Rad	NULL
)	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparations	NULL
and	NULL
binding	NULL
reactions	NULL
were	NULL
repeated	NULL
on	NULL
three	NULL
separate	NULL
occasions	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
stimulated	NULL
133	NULL
cells	NULL
was	NULL
suppressed	NULL
five-	NULL
to	NULL
sevenfold	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
22F6	NULL
cells	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
evident	NULL
40	NULL
min	NULL
poststimula-tion	NULL
and	NULL
was	NULL
sustained	NULL
throughout	NULL
the	NULL
4-h	NULL
stimulation	NULL
period	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

J25	NULL
clone	NULL
22D8	NULL
cells	NULL
represent	NULL
a	NULL
distinct	NULL
clonal	NULL
cell	NULL
line	NULL
which	NULL
,	NULL
like	NULL
the	NULL
133	NULL
cells	NULL
,	NULL
also	NULL
stably	NULL
express	NULL
Nef	NULL
(	NULL
21	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
induction	NULL
was	NULL
suppressed	NULL
four-	NULL
to	NULL
fivefold	NULL
in	NULL
the	NULL
22D8	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
22F6	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
suppression	NULL
was	NULL
more	NULL
profound	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
22D8	NULL
cells	NULL
,	NULL
which	NULL
correlates	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
Nef	NULL
expression	NULL
was	NULL
higher	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Similarly	NULL
to	NULL
the	NULL
Nef-expressing	NULL
J25	NULL
clones	NULL
,	NULL
Nef	NULL
inhibited	NULL
NF-KB	NULL
induction	NULL
three-	NULL
to	NULL
fourfold	NULL
in	NULL
the	NULL
Jurkat/LnefSN	NULL
and	NULL
HPB-ALL/	NULL
LnefSNS1	NULL
cells	NULL
compared	NULL
with	NULL
their	NULL
non-Nef-expressing	NULL
counterparts	NULL
(	NULL
Fig	NULL
.	NULL

2¢	NULL
and	NULL
d	NULL
)	NULL
.	NULL

Nef-mediated	NULL
NF-	NULL
«	NULL
B	NULL
suppression	NULL
was	NULL
more	NULL
profound	NULL
in	NULL
the	NULL
Jurkat/LnefSN	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
HPB-ALL/LnefSNS1	NULL
cells	NULL
,	NULL
even	NULL
though	NULL
the	NULL
HPB-ALL/	NULL
LnefSNS1	NULL
cells	NULL
expressed	NULL
severalfold	NULL
higher	NULL
levels	NULL
of	NULL
Nef	NULL
.	NULL

This	NULL
result	NULL
is	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
biological	NULL
differences	NULL
that	NULL
exist	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

That	NULL
is	NULL
,	NULL
Jurkat	NULL
cells	NULL
may	NULL
be	NULL
more	NULL
sensitive	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
Nef	NULL
than	NULL
HPB-ALL	NULL
cells	NULL
because	NULL
of	NULL
differential	NULL
expression	NULL
of	NULL
proteins	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

That	NULL
Nef-mediated	NULL
NF-	NULL
«	NULL
B	NULL
suppression	NULL
in	NULL
the	NULL
133	NULL
and	NULL
22D8	NULL
cells	NULL
was	NULL
greater	NULL
than	NULL
in	NULL
the	NULL
Jurkat/LnefSN	NULL
and	NULL
HPB-ALL/LnefSNS1	NULL
cells	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
different	NULL
nef	NULL
allele	NULL
in	NULL
the	NULL
133	NULL
and	NULL
22D8	NULL
cells	NULL
.	NULL

Alterna-tively	NULL
,	NULL
this	NULL
result	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
every	NULL
cell	NULL
in	NULL
the	NULL
culture	NULL
of	NULL
133	NULL
and	NULL
22D8	NULL
cells	NULL
produced	NULL
a	NULL
relatively	NULL
high	NULL
level	NULL
of	NULL
Nef	NULL
,	NULL
whereas	NULL
the	NULL
Jurkat/LnefSN	NULL
and	NULL
HPB-ALL/	NULL
LnefSNS1	NULL
cells	NULL
represent	NULL
a	NULL
mixed	NULL
population	NULL
of	NULL
cells	NULL
expressing	NULL
low	NULL
and	NULL
high	NULL
levels	NULL
of	NULL
Nef	NULL
or	NULL
no	NULL
Nef	NULL
at	NULL
all	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
nuclei	NULL
from	NULL
unstimulated	NULL
cells	NULL
was	NULL
extremely	NULL
low	NULL
but	NULL
detectable	NULL
,	NULL
and	NULL
no	NULL
differences	NULL
between	NULL
the	NULL
Nef-expressing	NULL
and	NULL
control	NULL
cells	NULL
were	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
when	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
un-	NULL
VoL	NULL
.	NULL

66	NULL
,	NULL
1992	NULL
NOTES	NULL
6215	NULL
[	NULL
NF-kB	NULL
|	NULL
SP-1	NULL
b	NULL
NF-kB	NULL
SP-1	NULL
mos	NULL
sg	NULL
g	NULL
o	NULL
®	NULL
w	NULL
t	NULL
soe	NULL
5	NULL
o*	NULL
cl	NULL
T	NULL
T	NULL
bo	NULL
&	NULL
v	NULL
®	NULL
&	NULL
o	NULL
®	NULL
£	NULL
&	NULL
7	NULL
S	NULL
*	NULL
&	NULL
&	NULL
5	NULL
8A	NULL
&	NULL
a	NULL
a	NULL
s	NULL
s	NULL
&	NULL
s	NULL
s	NULL
&	NULL
&	NULL
a	NULL
o	NULL
a	NULL
a	NULL
a	NULL
a	NULL
a	NULL
a	NULL
a	NULL
&	NULL
s	NULL
S	NULL
a	NULL
2	NULL
to	NULL
to	NULL
t	NULL
&	NULL
s	NULL
2	NULL
A9	NULL
#	NULL
=f	NULL
#	NULL
~	NULL
a	NULL
al	NULL
e	NULL
a_	NULL
ot	NULL
a_	NULL
af	NULL
©	NULL
S	NULL
%	NULL
2	NULL
c	NULL
S	NULL
A	NULL
T	NULL
ea	NULL
a	NULL
a	NULL
o	NULL
©	NULL
T	NULL
2	NULL
to	NULL
flo	NULL
T	NULL
n	NULL
nl	NULL
oe	NULL
#	NULL
i	NULL
%	NULL
a	NULL
8	NULL
2	NULL
~	NULL
2	NULL
a	NULL
2	NULL
;	NULL
s	NULL
I	NULL
§	NULL
1	NULL
&	NULL
T	NULL
L	NULL
TA	NULL
T	NULL
Vo	NULL
``	NULL
r	NULL
ag	NULL
g	NULL
8	NULL
ga	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
g	NULL
8	NULL
a	NULL
8	NULL
a	NULL
&	NULL
g	NULL
8	NULL
g	NULL
8	NULL
g	NULL
88	NULL
8	NULL
a	NULL
2	NULL
%	NULL
«	NULL
o_	NULL
@	NULL
4	NULL
@	NULL
4	NULL
N	NULL
4	NULL
Ao	NULL
H	NULL
a	NULL
-	NULL
a	NULL
Ro	NULL
n	NULL
24	NULL
a	NULL
_	NULL
oa	NULL
Aa	NULL
2	NULL
a	NULL
2	NULL
*	NULL
5	NULL
N	NULL
-	NULL
#	NULL
»	NULL
’	NULL
i	NULL
<	NULL
<	NULL
--	NULL
tou	NULL
_	NULL
buds	NULL
sud	NULL
bos	NULL
i	NULL
N	NULL
NF-kB	NULL
SP-1	NULL
Jurkat/Lfen	NULL
-	NULL
4	NULL
+	NULL
cold	NULL
Jurkat/Lnef-0	NULL
5	NULL
&	NULL
&	NULL
=	NULL
=	NULL
Jurkat/Lfen-0	NULL
Jurkat/Lnef-0	NULL
Jurkat/Lfen	NULL
-	NULL
4	NULL
bulk=s4	NULL
HPB-ALI	NULL
/Lfen	NULL
-	NULL
4	NULL
+	NULL
cold	NULL
SP-1	NULL
/LfenSN	NULL
+	NULL
cold	NULL
£-0	NULL
S	NULL
A/Lfen	NULL
-	NULL
4	NULL
+	NULL
cold	NULL
HPB-ALL/LnefSNS1	NULL
22F6	NULL
+	NULL
cold	NULL
2	NULL
m	NULL
22F6	NULL
133	NULL
U	NULL
HPB-ALL/LfenSN	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
J25	NULL
(	NULL
a	NULL
and	NULL
b	NULL
)	NULL
,	NULL
Jurkat	NULL
E6-1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
or	NULL
HPB-ALL	NULL
(	NULL
d	NULL
)	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
22F6	NULL
and	NULL
133	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
(	NULL
13	NULL
g/m	NULL
!	NULL
)	NULL

and	NULL
PMA	NULL
(	NULL
75	NULL
ng/ml	NULL
)	NULL
for	NULL
0	NULL
,	NULL
40	NULL
,	NULL
80	NULL
,	NULL
120	NULL
,	NULL
or	NULL
240	NULL
min	NULL
;	NULL
22F6	NULL
and	NULL
22D8	NULL
(	NULL
b	NULL
)	NULL
,	NULL
Jurkat	NULL
E6-1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
or	NULL
HPB-ALL	NULL
(	NULL
d	NULL
)	NULL
cells	NULL
were	NULL
not	NULL
stimulated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
as	NULL
described	NULL
above	NULL
for	NULL
4	NULL
h	NULL
(	NULL
4	NULL
)	NULL
.	NULL

DNA	NULL
probes	NULL
used	NULL
for	NULL
binding	NULL
are	NULL
specified	NULL
on	NULL
the	NULL
top	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

(	NULL
e	NULL
)	NULL
Cytoplasmic	NULL
protein	NULL
extracts	NULL
(	NULL
7	NULL
jpg	NULL
each	NULL
)	NULL
from	NULL
the	NULL
indicated	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
NF-kB	NULL
DNA	NULL
probe	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.6	NULL
%	NULL
deoxycholic	NULL
acid	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

N	NULL
,	NULL
S	NULL
,	NULL
and	NULL
P	NULL
,	NULL
NF-	NULL
«	NULL
B-specific	NULL
binding	NULL
,	NULL
SP-1-specific	NULL
binding	NULL
,	NULL
and	NULL
free	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

SP-1	NULL
binding	NULL
served	NULL
as	NULL
a	NULL
control	NULL
for	NULL
extract	NULL
quality	NULL
and	NULL
specificity	NULL
of	NULL
Nef	NULL
effects	NULL
.	NULL

Cold	NULL
indicates	NULL
that	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
DNA	NULL
was	NULL
added	NULL
for	NULL
competition	NULL
.	NULL

ns	NULL
,	NULL
nonspecific	NULL
binding	NULL
.	NULL

Data	NULL
represent	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

stimulated	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
deoxycholic	NULL
acid	NULL
(	NULL
which	NULL
releases	NULL
NF-KB	NULL
from	NULL
its	NULL
cytoplasmic	NULL
inhibitor	NULL
,	NULL
IB	NULL
[	NULL
3	NULL
]	NULL
)	NULL
,	NULL
they	NULL
exhibited	NULL
NF-kB	NULL
activity	NULL
independent	NULL
of	NULL
Nef	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

2e	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
that	NULL
Nef	NULL
suppressed	NULL
the	NULL
level	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
induction	NULL
after	NULL
only	NULL
40	NULL
min	NULL
of	NULL
stimulation	NULL
suggests	NULL
that	NULL
Nef	NULL
does	NULL
not	NULL
suppress	NULL
p1l10	NULL
or	NULL
p65	NULL
NF-kB	NULL
mRNA	NULL
expression	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
Nef	NULL
affects	NULL
the	NULL
recruitment	NULL
and	NULL
not	NULL
the	NULL
cytoplasmic	NULL
concentration	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
SP-1	NULL
was	NULL
independent	NULL
of	NULL
Nef	NULL
expression	NULL
and	NULL
stimula-	NULL
tion	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
SP-1	NULL
probe	NULL
used	NULL
in	NULL
these	NULL
gel	NULL
shift	NULL
assays	NULL
was	NULL
not	NULL
limiting	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
through	NULL
d	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
no	NULL
differences	NULL
in	NULL
binding	NULL
to	NULL
NF-AT-	NULL
,	NULL
USF-	NULL
,	NULL
and	NULL
URS-specific	NULL
probes	NULL
between	NULL
the	NULL
22F6	NULL
and	NULL
133	NULL
cells	NULL
were	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
Nef	NULL
specifically	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

To	NULL
further	NULL
demonstrate	NULL
Nef	NULL
's	NULL
suppressive	NULL
effect	NULL
on	NULL
NF-KB	NULL
recruitment	NULL
,	NULL
22F6	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
DNA	NULL
plasmids	NULL
expressing	NULL
Nef	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
pro	NULL
6216	NULL
NOTES	NULL
NF-kB	NULL
-	NULL
0	NULL
pCMVE/N	NULL
fs	NULL
-	NULL
4	NULL
22	NULL
-H	NULL
pSVE/N	NULL
fs	NULL
pSVE/N	NULL
fs	NULL
-	NULL
4	NULL
pSVE/N	NULL
-	NULL
4	NULL
pCMVE/N	NULL
fs	NULL
-	NULL
4	NULL
pCMVE/N	NULL
-	NULL
4	NULL
pSVE/N	NULL
fs	NULL
-	NULL
0	NULL
pSVE/N	NULL
fs	NULL
-	NULL
4	NULL
pSVE/N	NULL
-	NULL
4	NULL
pCMVE/N	NULL
-	NULL
4	NULL
|	NULL
M	NULL
cold	NULL
NF-kB	NULL
DNA	NULL
3	NULL
$	NULL
4	NULL
a	NULL
0	NULL
4	NULL
a.	NULL
anti-p50	NULL
anti-p65	NULL
anti-Nef	NULL
anti-rel	NULL
super	NULL
shift	NULL
super	NULL
shift	NULL
p6S5-p50	NULL
p50-p50	NULL
ns	NULL
moter	NULL
,	NULL
pSVF/N	NULL
,	NULL
or	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
promoter	NULL
,	NULL
pCMVF/N	NULL
,	NULL
or	NULL
with	NULL
plasmids	NULL
containing	NULL
frameshift	NULL
mutations	NULL
in	NULL
the	NULL
nef	NULL
gene	NULL
(	NULL
pSVF/N	NULL
fs	NULL
and	NULL
pCMVF/N	NULL
fs	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
DNA-binding	NULL
reactions	NULL
were	NULL
as	NULL
described	NULL
above	NULL
.	NULL

22F6	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10	NULL
``	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
gjlasmid	NULL
DNA	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
plasmid	NULL
DNA	NULL
suspended	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
10	NULL
ml	NULL
of	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
,	NULL
0.25	NULL
M	NULL
Tris	NULL
(	NULL
pH	NULL
7.3	NULL
)	NULL
,	NULL
and	NULL
125	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
at	NULL
37°C	NULL
for	NULL
40	NULL
min	NULL
.	NULL

Following	NULL
centrifugation	NULL
at	NULL
2,000	NULL
x	NULL
g	NULL
for	NULL
7	NULL
min	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
growth	NULL
medium	NULL
for	NULL
60	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
and	NULL
cell	NULL
harvesting	NULL
.	NULL

Plasmid	NULL
pSVF/N	NULL
is	NULL
similar	NULL
to	NULL
plasmid	NULL
pSVF	NULL
(	NULL
25	NULL
)	NULL
,	NULL
except	NULL
that	NULL
HIV-1	NULL
nucleotides	NULL
8994	NULL
to	NULL
9213	NULL
(	NULL
including	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
recognition	NULL
sites	NULL
)	NULL
and	NULL
3	NULL
'	NULL
flanking	NULL
cellular	NULL
sequences	NULL
were	NULL
deleted	NULL
.	NULL

Plasmid	NULL
pSVF/N	NULL
was	NULL
digested	NULL
at	NULL
the	NULL
unique	NULL
Bg/lI	NULL
site	NULL
at	NULL
codon	NULL
88	NULL
of	NULL
the	NULL
nef	NULL
gene	NULL
,	NULL
the	NULL
sticky	NULL
ends	NULL
were	NULL
filled	NULL
in	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
,	NULL
and	NULL
the	NULL
plasmid	NULL
was	NULL
religated	NULL
with	NULL
T4	NULL
DNA	NULL
ligase	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
called	NULL
pSVF/N	NULL
fs	NULL
to	NULL
indicate	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
frameshift	NULL
in	NULL
the	NULL
nef	NULL
gene	NULL
.	NULL

The	NULL
BamHI	NULL
133	NULL
-	NULL
H	NULL
22	NULL
J.	NULL
Viror	NULL
.	NULL

z	NULL
=	NULL
§	NULL
_	NULL
-	NULL
M	NULL
22	NULL
-	NULL
H+M	NULL
133	NULL
-	NULL
H+M	NULL
22	NULL
-	NULL
H+	NULL
]	NULL
133	NULL
-	NULL
H+	NULL
]	NULL
22	NULL
-	NULL
M+I	NULL
133	NULL
-	NULL
M+I	NULL
H	NULL
22	NULL
-	NULL
H+M	NULL
133	NULL
-	NULL
H+M	NULL
22	NULL
-	NULL
H+I	NULL
133	NULL
-	NULL
M	NULL
133	NULL
-	NULL
M	NULL
133	NULL
-	NULL
H	NULL
22	NULL
-	NULL
M	NULL
22	NULL
wir	NULL
£4	NULL
thotk	NULL
44	NULL
,	NULL
broek	NULL
bond	NULL
dosed	NULL
fa	NULL
dne	NULL
Qual	NULL
leat	NULL
i-	NULL
thd	NULL
ht	NULL
a+	NULL
+	NULL
d	NULL
bol	NULL
fu	NULL
oon	NULL
Aout	NULL
Goal	NULL
a	NULL
“	NULL
ﬁgs	NULL
bubs	NULL
Rob	NULL
Wo	NULL
ma	NULL
outh	NULL
wee	NULL
we	NULL
--	NULL
p	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
22F6	NULL
cells	NULL
(	NULL
a	NULL
)	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
DNA	NULL
plasmids	NULL
that	NULL
were	NULL
not	NULL
stimulated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
(	NULL
4	NULL
)	NULL
with	NULL
PHA-P	NULL
and	NULL
PMA	NULL
and	NULL
22F6	NULL
and	NULL
133	NULL
cells	NULL
(	NULL
b	NULL
)	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
PHA-P	NULL
(	NULL
H	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
M	NULL
)	NULL
,	NULL
or	NULL
ionomycin	NULL
(	NULL
I	NULL
)	NULL
(	NULL
2	NULL
M	NULL
)	NULL
or	NULL
combinations	NULL
of	NULL
any	NULL
two	NULL
mitogens	NULL
.	NULL

N	NULL
,	NULL
U	NULL
,	NULL
S	NULL
,	NULL
and	NULL
P	NULL
,	NULL
NF-	NULL
«	NULL
B-specific	NULL
binding	NULL
,	NULL
USF-specific	NULL
binding	NULL
,	NULL
SP-1-specific	NULL
binding	NULL
,	NULL
and	NULL
free	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Nuclear	NULL
extract	NULL
22F6	NULL
H+M	NULL
from	NULL
panel	NULL
b	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
specified	NULL
antiserum	NULL
for	NULL
15	NULL
min	NULL
before	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

NF-kB	NULL
p65-p50	NULL
heterodimer-	NULL
and	NULL
p50-p50	NULL
homodimer-DNA	NULL
complexes	NULL
and	NULL
supershifted	NULL
heterodimer-	NULL
and	NULL
homodimer-DNA-antibody	NULL
complexes	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
right	NULL
.	NULL

Data	NULL
represent	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

fragment	NULL
from	NULL
pSVF/N	NULL
and	NULL
pSVF/N	NULL
fs	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
entire	NULL
length	NULL
of	NULL
the	NULL
HIV-1	NULL
sequences	NULL
present	NULL
in	NULL
these	NULL
clones	NULL
,	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
vector	NULL
pCB6	NULL
(	NULL
24	NULL
)	NULL
in	NULL
the	NULL
correct	NULL
orientation	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
promoter	NULL
to	NULL
generate	NULL
clones	NULL
pCMVF/N	NULL
and	NULL
pCMVF/N	NULL
fs	NULL
,	NULL
respectively	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
plasmids	NULL
pSVF/N	NULL
and	NULL
pCMVF/N	NULL
express	NULL
Nef	NULL
protein	NULL
,	NULL
but	NULL
cells	NULL
transfected	NULL
with	NULL
pSVF/N	NULL
fs	NULL
and	NULL
pCMVF/N	NULL
fs	NULL
do	NULL
not	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
and	NULL
immunoprecipitation	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
determined	NULL
by	NULL
cotrans-fection	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
pSV2-CAT	NULL
.	NULL

Chloramphenicol	NULL
acetyl-transferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
(	NULL
reported	NULL
as	NULL
the	NULL
percent	NULL
conversion	NULL
to	NULL
acetylated	NULL
products	NULL
)	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
below	NULL
,	NULL
and	NULL
the	NULL
values	NULL
for	NULL
the	NULL
pSVF/N	NULL
fs-0-	NULL
,	NULL
pSVF/N	NULL
fs-4-	NULL
,	NULL
pSVF/N-4-	NULL
,	NULL
pCMVF/N	NULL
fs-4-	NULL
,	NULL
and	NULL
pCMVF/N-4-transfected	NULL
cells	NULL
were	NULL
51	NULL
,	NULL
60	NULL
,	NULL
61	NULL
,	NULL
58	NULL
,	NULL
and	NULL
61	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
USF-specific	NULL
DNA	NULL
probe	NULL
(	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-159	NULL
to	NULL
-173	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
GCCGCTAG	NULL
CATTTCATCACGTGGCCCGAGAGCTGC	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
Nef	NULL
effects	NULL
and	NULL
extract	NULL
integrity	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
induction	NULL
was	NULL
consistently	NULL
inhibited	NULL
at	NULL
least	NULL
twofold	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
pSVF/N	NULL
or	NULL
pCMVF/N	NULL
compared	NULL
with	NULL
cells	NULL
transfected	NULL
with	NULL
their	NULL
nef	NULL
mutant	NULL
counterparts	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
in	NULL
these	NULL
experiments	NULL
were	NULL
determined	NULL
by	NULL
cotransfecting	NULL
cells	NULL
with	NULL
the	NULL
pSV2-CAT	NULL
plasmid	NULL
and	NULL
measuring	NULL
CAT	NULL
activity	NULL
.	NULL

No	NULL
significant	NULL
differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
between	NULL
the	NULL
nef-expressing	NULL
and	NULL
the	NULL
nef	NULL
mutant	NULL
plasmids	NULL
were	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

The	NULL
suppressive	NULL
effect	NULL
of	NULL
Nef	NULL
in	NULL
these	NULL
transiently	NULL
transfected	NULL
cells	NULL
was	NULL
not	NULL
as	NULL
dramatic	NULL
as	NULL
the	NULL
effects	NULL
observed	NULL
in	NULL
the	NULL
stably	NULL
transfected	NULL
and	NULL
transduced	NULL
cells	NULL
.	NULL

The	NULL
more	NULL
subtle	NULL
effect	NULL
of	NULL
Nef	NULL
in	NULL
this	NULL
experiment	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
ref	NULL
allele	NULL
which	NULL
was	NULL
derived	NULL
from	NULL
an	NULL
HIV-1	NULL
isolate	NULL
distinct	NULL
from	NULL
either	NULL
the	NULL
NL-43	NULL
or	NULL
the	NULL
SF2	NULL
isolates	NULL
Vor	NULL
.	NULL

66	NULL
,	NULL
1992	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cells	NULL
which	NULL
did	NULL
not	NULL
receive	NULL
the	NULL
nef	NULL
expression	NULL
plasmid	NULL
during	NULL
the	NULL
transient-transfection	NULL
process	NULL
were	NULL
not	NULL
eliminated	NULL
(	NULL
by	NULL
antibiotic	NULL
selection	NULL
)	NULL
from	NULL
the	NULL
total	NULL
cell	NULL
population	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
relative	NULL
contributions	NULL
of	NULL
individual	NULL
mitogens	NULL
to	NULL
the	NULL
recruitment	NULL
of	NULL
Nef-inhibitable	NULL
complexes	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
ionomycin	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
.	NULL

The	NULL
maximal	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
occurred	NULL
when	NULL
PHA	NULL
was	NULL
combined	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

This	NULL
result	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
PHA	NULL
mimics	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
natural	NULL
ligand	NULL
for	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
complex	NULL
(	NULL
32	NULL
)	NULL
,	NULL
suggests	NULL
that	NULL
Nef	NULL
may	NULL
inhibit	NULL
signal	NULL
transduction	NULL
emanating	NULL
from	NULL
the	NULL
TCR	NULL
complex	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
the	NULL
Ca**	NULL
ionophore	NULL
,	NULL
ionomycin	NULL
,	NULL
when	NULL
coupled	NULL
with	NULL
PMA	NULL
treat-ment	NULL
,	NULL
partially	NULL
substituted	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
PHA	NULL
with	NULL
respect	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

However	NULL
,	NULL
ionomycin	NULL
treatment	NULL
did	NULL
not	NULL
significantly	NULL
reduce	NULL
Nef	NULL
's	NULL
inhibitory	NULL
ef-fects	NULL
,	NULL
suggesting	NULL
that	NULL
events	NULL
other	NULL
than	NULL
Ca**	NULL
mobilization	NULL
may	NULL
be	NULL
disrupted	NULL
by	NULL
Nef	NULL
.	NULL

Using	NULL
antibodies	NULL
against	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Nef-inhibitable	NULL
complexes	NULL
included	NULL
both	NULL
p50-p50	NULL
homodimers	NULL
and	NULL
pS50-p65	NULL
heterodimers	NULL
(	NULL
Fig	NULL
.	NULL

3¢	NULL
)	NULL
.	NULL

Anti-p50	NULL
,	NULL
anti-p65	NULL
,	NULL
anti-v-re/	NULL
,	NULL
and	NULL
prebleed	NULL
sera	NULL
(	NULL
Fig	NULL
.	NULL

3¢	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Mark	NULL
Hannink	NULL
(	NULL
University	NULL
of	NULL
Missouri	NULL
,	NULL
Columbia	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

.	NULL

Because	NULL
the	NULL
gels	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
and	NULL
b	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
were	NULL
run	NULL
for	NULL
a	NULL
shorter	NULL
length	NULL
of	NULL
time	NULL
,	NULL
the	NULL
two	NULL
bands	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

3¢	NULL
appear	NULL
as	NULL
one	NULL
band	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
and	NULL
b	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Nef-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
correlated	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
transcriptional	NULL
activity	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
DNA	NULL
plasmids	NULL
which	NULL
use	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
to	NULL
direct	NULL
expression	NULL
of	NULL
a	NULL
heterologous	NULL
gene	NULL
product	NULL
,	NULL
CAT	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
trans-fected	NULL
,	NULL
as	NULL
described	NULL
above	NULL
,	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
the	NULL
CAT	NULL
constructs	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
growth	NULL
medium	NULL
for	NULL
24	NULL
h.	NULL
Cells	NULL
were	NULL
or	NULL
were	NULL
not	NULL
treated	NULL
with	NULL
PHA-P	NULL
(	NULL
13	NULL
pg/ml	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
75	NULL
ng/ml	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
18	NULL
h.	NULL
Cell	NULL
extracts	NULL
were	NULL
pre-pared	NULL
,	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
assessed	NULL
by	NULL
standard	NULL
methods	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Extract	NULL
equivalent	NULL
to	NULL
3	NULL
x	NULL
10°	NULL
cells	NULL
was	NULL
used	NULL
for	NULL
each	NULL
18-h	NULL
reaction	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
analysis	NULL
with	NULL
respect	NULL
to	NULL
extract	NULL
amount	NULL
and	NULL
incubation	NULL
time	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
normalized	NULL
to	NULL
a	NULL
nonin-ducible	NULL
control	NULL
plasmid	NULL
,	NULL
RSV-CAT	NULL
(	NULL
12	NULL
)	NULL
(	NULL
2	NULL
mg	NULL
)	NULL
,	NULL
which	NULL
was	NULL
transfected	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
HIV-1-CAT	NULL
plasmids	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Assays	NULL
were	NULL
also	NULL
normalized	NULL
to	NULL
protein	NULL
concentrations	NULL
as	NULL
determined	NULL
by	NULL
Bradford	NULL
reagent	NULL
analysis	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
quantitated	NULL
by	NULL
excising	NULL
the	NULL
spots	NULL
corresponding	NULL
to	NULL
the	NULL
unacetylated	NULL
and	NULL
acetylated	NULL
forms	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
and	NULL
measuring	NULL
radioactivity	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

CAT	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
radioactivity	NULL
in	NULL
the	NULL
acetylated	NULL
forms	NULL
compared	NULL
with	NULL
the	NULL
sum	NULL
of	NULL
that	NULL
of	NULL
the	NULL
acetylated	NULL
and	NULL
unacetylated	NULL
forms	NULL
.	NULL

The	NULL
wild-type	NULL
HIV-1-CAT	NULL
(	NULL
CD12-CAT	NULL
was	NULL
derived	NULL
by	NULL
a	NULL
small	NULL
deletion	NULL
in	NULL
the	NULL
mef	NULL
coding	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
start	NULL
site	NULL
of	NULL
clone	NULL
C15-CAT	NULL
[	NULL
2	NULL
]	NULL
)	NULL
,	NULL
and	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
HIV-1-CAT	NULL
(	NULL
23	NULL
)	NULL
and	NULL
IL-2-CAT	NULL
(	NULL
30	NULL
)	NULL
plasmids	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Steven	NULL
Josephs	NULL
,	NULL
Gary	NULL
Nabel	NULL
,	NULL
and	NULL
Gerald	NULL
Crabtree	NULL
,	NULL
respectively	NULL
.	NULL

SNRE-HIV-1-CAT	NULL
was	NULL
generated	NULL
by	NULL
excising	NULL
the	NULL
Aval-4val	NULL
fragment	NULL
from	NULL
C15-CAT	NULL
(	NULL
2	NULL
)	NULL
and	NULL
therefore	NULL
lacks	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
sequences	NULL
present	NULL
in	NULL
C15-CAT	NULL
.	NULL

CAT	NULL
activity	NULL
correlated	NULL
well	NULL
with	NULL
DNA-binding	NULL
activity	NULL
in	NULL
that	NULL
133	NULL
cells	NULL
exhibited	NULL
a	NULL
capacity	NULL
to	NULL
induce	NULL
CAT	NULL
activity	NULL
that	NULL
was	NULL
fivefold	NULL
less	NULL
than	NULL
that	NULL
of	NULL
22F6	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
CAT	NULL
activity	NULL
induction	NULL
was	NULL
suppressed	NULL
twofold	NULL
in	NULL
NOTES	NULL
6217	NULL
HIV-1-CAT	NULL
NF-kB	NULL
mutant	NULL
HIV-1-C	NULL
AT	NULL
ul	NULL
133	NULL
22r6	NULL
(	NULL
RS	NULL
*	NULL
%	NULL
#	NULL
@	NULL
0.2	NULL
43	NULL
0.3	NULL
1.3	NULL
0.2	NULL
0.3	NULL
6.3	NULL
04	NULL
IL-2-CAT	NULL
22r6	NULL
133	NULL
22r6	NULL
133	NULL
1	NULL
1	NULL
r	NULL
r	NULL
f	NULL
_	NULL
*	NULL
<	NULL
ofet	NULL
chee	NULL
HIV-1-CAT	NULL
NF-kB	NULL
mutant	NULL
HTV-1-CAT	NULL
Jurkat/LfenSN	NULL
Jurkat/LnefSN	NULL
r	NULL
ir	NULL
1	NULL
l	NULL
ir	NULL
JurkaULfenSN	NULL
Jurkat/LnefSN	NULL
AC	NULL
@	NULL
<	NULL
ogee	NULL
rere	NULL
induction	NULL
-	NULL
F	NULL
e	NULL
+	NULL
6	NULL
+	NULL
F	NULL
he	NULL
percent	NULL
conversion	NULL
0.3	NULL
3.1	NULL
0.3	NULL
BJ	NULL
0.2	NULL
0.3	NULL
0.2	NULL
0.2	NULL
NRE-HIV-1-CAT	NULL
IL-2-CAT	NULL
Jurkat/LfenSN	NULL
Jurkat/LnefSN	NULL
Jurkat/LfenSN	NULL
Jurkat/LnefSN	NULL
E-	NULL
--	NULL
f	NULL
1	NULL
r	NULL
|	NULL
AMIR	NULL
©	NULL
eevee	NULL
orer	NULL
induction	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
percent	NULL
conversion	NULL
2.0	NULL
-	NULL
23.1	NULL
1.2	NULL
4.7	NULL
<	NULL
0.05	NULL
0.3	NULL
<	NULL
0.05	NULL
<	NULL
0.05	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

CAT	NULL
assays	NULL
of	NULL
extracts	NULL
from	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
HIV-1-CAT	NULL
and	NULL
IL-2-CAT	NULL
DNA	NULL
plasmids	NULL
.	NULL

J25	NULL
(	NULL
a	NULL
)	NULL
and	NULL
Jurkat	NULL
E6-1	NULL
(	NULL
b	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CAT	NULL
constructs	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
panel	NULL
.	NULL

Cells	NULL
were	NULL
not	NULL
induced	NULL
(	NULL
-	NULL
)	NULL
or	NULL
were	NULL
induced	NULL
(	NULL
+	NULL
)	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
conversion	NULL
of	NULL
unacetylated	NULL
[	NULL
**C	NULL
)	NULL
chloramphenicol	NULL
(	NULL
CM	NULL
)	NULL
to	NULL
monoacetylated	NULL
forms	NULL
(	NULL
AC	NULL
)	NULL
.	NULL

These	NULL
data	NULL
represent	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

the	NULL
Jurkat/LnefSN	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
Jurkat/	NULL
LfenSN	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
demonstrated	NULL
with	NULL
both	NULL
wild-type	NULL
HIV-1-CAT	NULL
and	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
deletion	NULL
clone	NULL
,	NULL
SNRE-HIV-1-CAT	NULL
,	NULL
which	NULL
lacks	NULL
nucleotides	NULL
-453	NULL
to	NULL
-156	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
6218	NULL
NOTES	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
negative	NULL
regulatory	NULL
element	NULL
sequences	NULL
are	NULL
not	NULL
primary	NULL
targets	NULL
of	NULL
Nef	NULL
regulation	NULL
in	NULL
stimulated	NULL
T	NULL
cells	NULL
.	NULL

An	NULL
HIV-1-CAT	NULL
plasmid	NULL
containing	NULL
mutated	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
(	NULL
23	NULL
)	NULL
was	NULL
induced	NULL
,	NULL
at	NULL
most	NULL
,	NULL
only	NULL
twofold	NULL
above	NULL
basal	NULL
levels	NULL
,	NULL
and	NULL
induction	NULL
was	NULL
independent	NULL
of	NULL
cell	NULL
type	NULL
and	NULL
Nef	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
by	NULL
T-cell	NULL
mitogens	NULL
was	NULL
demonstrated	NULL
by	NULL
Hoyos	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
.	NULL

These	NULL
authors	NULL
showed	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
prevented	NULL
up	NULL
to	NULL
80	NULL
%	NULL
with	NULL
IL-2-CAT	NULL
constructs	NULL
bearing	NULL
mutations	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
IL-2-CAT	NULL
constructs	NULL
containing	NULL
wild-type	NULL
NF-KB	NULL
recognition	NULL
sequences	NULL
(	NULL
17	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
21	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Nef	NULL
profoundly	NULL
suppressed	NULL
the	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
directed	NULL
by	NULL
the	NULL
IL-2-CAT	NULL
plasmid	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

Whereas	NULL
there	NULL
was	NULL
a	NULL
50-	NULL
to	NULL
60-fold	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
22F6	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
only	NULL
a	NULL
2-	NULL
to	NULL
3-fold	NULL
induction	NULL
in	NULL
the	NULL
133	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

Although	NULL
NF-	NULL
«	NULL
B	NULL
appears	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
IL-2	NULL
induction	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Nef	NULL
blocks	NULL
other	NULL
factors	NULL
in	NULL
addition	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
which	NULL
may	NULL
be	NULL
required	NULL
for	NULL
the	NULL
efficient	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
possibility	NULL
may	NULL
explain	NULL
the	NULL
dramatic	NULL
suppressive	NULL
effect	NULL
of	NULL
Nef	NULL
on	NULL
IL-2	NULL
induction	NULL
compared	NULL
with	NULL
the	NULL
results	NULL
of	NULL
Hoyos	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
generated	NULL
by	NULL
the	NULL
IL-2-CAT	NULL
construct	NULL
was	NULL
induced	NULL
to	NULL
a	NULL
much	NULL
lower	NULL
extent	NULL
in	NULL
the	NULL
Jurkat	NULL
E6-1	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
is	NULL
likely	NULL
due	NULL
to	NULL
differences	NULL
that	NULL
exist	NULL
between	NULL
Jurkat	NULL
E6-1	NULL
and	NULL
J25	NULL
cells	NULL
.	NULL

Despite	NULL
the	NULL
low	NULL
level	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
the	NULL
Jurkat	NULL
E6-1	NULL
cells	NULL
,	NULL
CAT	NULL
activity	NULL
was	NULL
higher	NULL
in	NULL
the	NULL
Jurkat/LfenSN	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
Jurkat/LnefSN	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

Nef	NULL
did	NULL
not	NULL
affect	NULL
CAT	NULL
activity	NULL
driven	NULL
by	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
or	NULL
the	NULL
promoters	NULL
from	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
,	NULL
cytomegalovirus	NULL
,	NULL
or	NULL
Mason-Pfizer	NULL
monkey	NULL
virus	NULL
,	NULL
indicating	NULL
that	NULL
Nef	NULL
specifically	NULL
suppressed	NULL
the	NULL
HIV-1	NULL
and	NULL
IL-2	NULL
promoters	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Jurkat	NULL
E6-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
equivalent	NULL
efficiency	NULL
;	NULL
however	NULL
,	NULL
the	NULL
Nef-expressing	NULL
133	NULL
cells	NULL
were	NULL
more	NULL
easily	NULL
transfected	NULL
than	NULL
were	NULL
the	NULL
control	NULL
cells	NULL
(	NULL
22F6	NULL
cells	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
CAT	NULL
activity	NULL
generated	NULL
by	NULL
an	NULL
RSV-CAT	NULL
plasmid	NULL
that	NULL
was	NULL
transfected	NULL
in	NULL
parallel	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
the	NULL
transfection	NULL
efficiency	NULL
and	NULL
to	NULL
normalize	NULL
the	NULL
CAT	NULL
activity	NULL
derived	NULL
from	NULL
the	NULL
HIV-1-CAT	NULL
and	NULL
IL-2-CAT	NULL
constructs	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
Nef	NULL
prevents	NULL
IL-2	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
(	NULL
21	NULL
)	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
demonstrations	NULL
that	NULL
IL-2	NULL
induction	NULL
requires	NULL
CD4	NULL
and	NULL
p56**	NULL
(	NULL
11	NULL
)	NULL
and	NULL
recruitment	NULL
(	NULL
17	NULL
)	NULL
,	NULL
provides	NULL
additional	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
Nef	NULL
uncouples	NULL
signals	NULL
originating	NULL
from	NULL
the	NULL
TCR	NULL
complex	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
TCR	NULL
complex	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
after	NULL
treatment	NULL
with	NULL
antibodies	NULL
to	NULL
either	NULL
CD2	NULL
or	NULL
CD3	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Nef	NULL
inhibits	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
by	NULL
both	NULL
of	NULL
these	NULL
stimuli	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Nef	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
down-modulate	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
CD4	NULL
(	NULL
10	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Although	NULL
Nef	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
rate	NULL
of	NULL
CD4	NULL
transcription	NULL
or	NULL
translation	NULL
(	NULL
10	NULL
)	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Nef	NULL
mediates	NULL
the	NULL
down-modulation	NULL
of	NULL
CD4	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
remains	NULL
unclear	NULL
.	NULL

The	NULL
connection	NULL
between	NULL
Nef-mediated	NULL
negative	NULL
effects	NULL
on	NULL
CD4	NULL
cell	NULL
surface	NULL
expression	NULL
and	NULL
HIV-1	NULL
and	NULL
IL-2	NULL
regulation	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
established	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
and	NULL
others	NULL
reported	NULL
that	NULL
HIV-1	NULL
Nef	NULL
mediated	NULL
HIV-1	NULL
transcriptional	NULL
suppression	NULL
(	NULL
1	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Some	NULL
investigators	NULL
were	NULL
unable	NULL
to	NULL
confirm	NULL
this	NULL
effect	NULL
(	NULL
16	NULL
,	NULL
19	NULL
)	NULL
;	NULL
however	NULL
,	NULL
differences	NULL
in	NULL
experimental	NULL
approaches	NULL
may	NULL
explain	NULL
the	NULL
apparent	NULL
discrepancy	NULL
.	NULL

For	NULL
the	NULL
first	NULL
time	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
the	NULL
primary	NULL
underlying	NULL
event	NULL
in	NULL
Nef-mediated	NULL
transcriptional	NULL
repression	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
inhibition	NULL
of	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
this	NULL
suppression	NULL
may	NULL
limit	NULL
the	NULL
production	NULL
and	NULL
cell	NULL
surface	NULL
J.	NULL
Viror	NULL
.	NULL

expression	NULL
of	NULL
viral	NULL
gene	NULL
products	NULL
in	NULL
infected	NULL
cells	NULL
,	NULL
thereby	NULL
allowing	NULL
the	NULL
cells	NULL
to	NULL
evade	NULL
clearance	NULL
by	NULL
the	NULL
cellular	NULL
and	NULL
humoral	NULL
arms	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

This	NULL
model	NULL
for	NULL
Nef-mediated	NULL
viral	NULL
persistence	NULL
in	NULL
vivo	NULL
may	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
Kestler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
which	NULL
demonstrated	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
nef	NULL
gene	NULL
was	NULL
required	NULL
to	NULL
prolong	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
and	NULL
induce	NULL
pathogenesis	NULL
in	NULL
infected	NULL
macaques	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
and	NULL
others	NULL
demonstrated	NULL
that	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
Nef	NULL
inhibited	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
way	NULL
that	NULL
was	NULL
analogous	NULL
to	NULL
the	NULL
way	NULL
in	NULL
which	NULL
HIV-1	NULL
Nef	NULL
inhibited	NULL
HIV-1	NULL
(	NULL
4	NULL
,	NULL
24	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
high-level	NULL
Nef	NULL
expression	NULL
early	NULL
after	NULL
infection	NULL
(	NULL
28	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
maintain	NULL
HIV-1	NULL
in	NULL
a	NULL
relatively	NULL
latent	NULL
state	NULL
,	NULL
which	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
establishing	NULL
a	NULL
reservoir	NULL
of	NULL
HIV-l-infected	NULL
cells	NULL
and	NULL
the	NULL
eventual	NULL
development	NULL
of	NULL
AIDS	NULL
.	NULL

We	NULL
thank	NULL
Lisa	NULL
Westfield	NULL
and	NULL
Evan	NULL
Sadler	NULL
for	NULL
oligonucleotides	NULL
,	NULL
Jason	NULL
Kimata	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
and	NULL
Alec	NULL
Cheng	NULL
for	NULL
excellent	NULL
technical	NULL
advice	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grant	NULL
A124745	NULL
and	NULL
U.S.	NULL
Army	NULL
grant	NULL
DAMD-17-90C-0125	NULL
to	NULL
L.R	NULL
.	NULL

,	NULL
National	NULL
Institute	NULL
of	NULL
Health	NULL
training	NULL
grant	NULL
HL-07088-17	NULL
to	NULL
T.M.J.N	NULL
.	NULL

,	NULL
American	NULL
Federation	NULL
for	NULL
AIDS	NULL
Research	NULL
grant	NULL
1405	NULL
to	NULL
J.V.G	NULL
.	NULL

,	NULL
and	NULL
the	NULL
Washington	NULL
University	NULL
Medical	NULL
Scientist	NULL
Training	NULL
Program	NULL
to	NULL
T.M.J.N	NULL
.	NULL

L.R	NULL
.	NULL

is	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
research	NULL
professor	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ahmad	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
S.	NULL
Venkatesan	NULL
.	NULL

1988	NULL
.	NULL

Nef	NULL
protein	NULL
of	NULL
HIV-1	NULL
is	NULL
a	NULL
transcriptional	NULL
repressor	NULL
of	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Science	NULL
241:1481-1485	NULL
.	NULL

2	NULL
.	NULL

Arya	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
G.	NULL
Chan	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1985	NULL
.	NULL

Trans-activator	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
(	NULL
HTLV-III	NULL
)	NULL
.	NULL

Science	NULL
229:69-73	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
§3:211-217	NULL
.	NULL

4	NULL
.	NULL

Binninger	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Ennen	NULL
,	NULL
D.	NULL
Bonn	NULL
,	NULL
S.	NULL
G.	NULL
Norley	NULL
,	NULL
and	NULL
R.	NULL
Kurth	NULL
.	NULL

1991	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
SIVmac	NULL
nef	NULL
gene	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:5237-5243	NULL
.	NULL

5	NULL
.	NULL

Bressler	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Pantaleo	NULL
,	NULL
A.	NULL
Demaria	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1991	NULL
.	NULL

Anti-CD2	NULL
receptor	NULL
antibodies	NULL
activate	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2290-2294	NULL
.	NULL

6	NULL
.	NULL

Bryant	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
L.	NULL
Ratner	NULL
,	NULL
R.	NULL
J.	NULL
Duronio	NULL
,	NULL
N.	NULL
S.	NULL
Kishore	NULL
,	NULL
B.	NULL
Devadas	NULL
,	NULL
S.	NULL
P.	NULL
Adams	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Gordon	NULL
.	NULL

1991	NULL
.	NULL

Incorporation	NULL
of	NULL
12-methoxydodecanoate	NULL
into	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
gag	NULL
polyprotein	NULL
precursor	NULL
inhibits	NULL
its	NULL
proteolytic	NULL
processing	NULL
and	NULL
virus	NULL
production	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
human	NULL
lym-phoid	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:2055-2059	NULL
.	NULL

7	NULL
.	NULL

Cheng-Mayer	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Ianello	NULL
,	NULL
K.	NULL
Shaw	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Levy	NULL
.	NULL

1989	NULL
.	NULL

Differential	NULL
effects	NULL
of	NULL
nef	NULL
on	NULL
HIV	NULL
replication	NULL
:	NULL
implications	NULL
for	NULL
viral	NULL
pathogenesis	NULL
in	NULL
the	NULL
host	NULL
.	NULL

Science	NULL
246	NULL
:	NULL
1629-1632	NULL
.	NULL

8	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebowitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

9	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
M.	NULL
Powell	NULL
,	NULL
M.	NULL
M.	NULL
Lightfoote	NULL
,	NULL
S.	NULL
Benn	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
HTLV-III/LAV	NULL
from	NULL
a	NULL
nonvirus-producing	NULL
T-cell	NULL
line	NULL
:	NULL
implications	NULL
for	NULL
latency	NULL
.	NULL

Science	NULL
231:600-602	NULL
.	NULL

10	NULL
.	NULL

Garcia	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Miller	NULL
.	NULL

1991	NULL
.	NULL

Serine	NULL
phosphorylation-independent	NULL
downregulation	NULL
of	NULL
cell-surface	NULL
CD4	NULL
by	NULL
nef	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:508-511	NULL
.	NULL

11	NULL
.	NULL

Glaichenhaus	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Shastri	NULL
,	NULL
D.	NULL
Littman	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Turner	NULL
.	NULL

1991	NULL
.	NULL

Requirement	NULL
for	NULL
association	NULL
of	NULL
p56	NULL
``	NULL
with	NULL
CD4	NULL
in	NULL
antigen-specific	NULL
signal	NULL
transduction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
64:511-520	NULL
.	NULL

12	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
G.	NULL
T.	NULL
Merlino	NULL
,	NULL
M.	NULL
C.	NULL
Willingham	NULL
,	NULL
I.	NULL
Pastan	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

The	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
is	NULL
a	NULL
strong	NULL
promoter	NULL
when	NULL
introduced	NULL
into	NULL
a	NULL
variety	NULL
of	NULL
eukaryotic	NULL
cells	NULL
by	NULL
DNA-mediated	NULL
transfection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Vor	NULL
.	NULL

66	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:6777-6781	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyl-transferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
1991	NULL
.	NULL

The	NULL
molecular	NULL
biology	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

324:308-317	NULL
.	NULL

Guy	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
P.	NULL
Kieny	NULL
,	NULL
Y.	NULL
Riviere	NULL
,	NULL
C.	NULL
LePeuch	NULL
,	NULL
K.	NULL
Dott	NULL
,	NULL
M.	NULL
Girard	NULL
,	NULL
L.	NULL
Montagnier	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Lecocg	NULL
.	NULL

1987	NULL
.	NULL

HIV	NULL
F/3	NULL
'	NULL
orf	NULL
encodes	NULL
a	NULL
phosphorylated	NULL
GTP-binding	NULL
protein	NULL
resembling	NULL
an	NULL
oncogene	NULL
product	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
330:266-269	NULL
.	NULL

Hammes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
M.	NULL
H.	NULL
Malim	NULL
,	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Nef	NULL
protein	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
evidence	NULL
against	NULL
its	NULL
role	NULL
as	NULL
a	NULL
transcriptional	NULL
inhibitor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:9549-9553	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohniein	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Kappa	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244:457-460	NULL
.	NULL

Kestler	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
D.	NULL
J.	NULL
Ringler	NULL
,	NULL
K.	NULL
Mori	NULL
,	NULL
D.	NULL
L.	NULL
Panicali	NULL
,	NULL
P.	NULL
K.	NULL
Sehgal	NULL
,	NULL
M.	NULL
D.	NULL
Daniel	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
.	NULL

1991	NULL
.	NULL

Importance	NULL
of	NULL
the	NULL
nef	NULL
gene	NULL
for	NULL
maintenance	NULL
of	NULL
high	NULL
virus	NULL
loads	NULL
and	NULL
for	NULL
development	NULL
of	NULL
AIDS	NULL
.	NULL

Cell	NULL
65:651-662	NULL
.	NULL

Kim	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Ikeuchi	NULL
,	NULL
R.	NULL
Byrn	NULL
,	NULL
J.	NULL
Groopman	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Lack	NULL
of	NULL
a	NULL
negative	NULL
influence	NULL
on	NULL
viral	NULL
growth	NULL
by	NULL
the	NULL
nef	NULL
gene	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:9544-9548.	NULL
.	NULL

Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
C.	NULL
Cheng-Mayer	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Levy	NULL
.	NULL

1987	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
:	NULL
the	NULL
orf-B	NULL
region	NULL
down-regulates	NULL
virus	NULL
replication	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:1434-1438	NULL
.	NULL

Luria	NULL
,	NULL
S.	NULL
,	NULL
I	NULL
.	NULL

Chambers	NULL
,	NULL
and	NULL
P.	NULL
Berg	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
nef	NULL
protein	NULL
in	NULL
T	NULL
cells	NULL
prevents	NULL
antigen	NULL
receptor-mediated	NULL
induction	NULL
of	NULL
interleukin	NULL
2	NULL
mRNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5326-5330	NULL
.	NULL

Montminy	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Bilezikjian	NULL
.	NULL

1987	NULL
.	NULL

Binding	NULL
of	NULL
a	NULL
nuclear	NULL
protein	NULL
to	NULL
the	NULL
cyclic-AMP	NULL
response	NULL
element	NULL
of	NULL
the	NULL
somatostatin	NULL
gene	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
328:175-178.	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713.	NULL
.	NULL

Niederman	NULL
,	NULL
T.	NULL
M.	NULL
J.	NULL
,	NULL
W.	NULL
Hu	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1991	NULL
.	NULL

Simian	NULL
immunodeficiency	NULL
virus	NULL
negative	NULL
factor	NULL
suppresses	NULL
the	NULL
level	NULL
of	NULL
viral	NULL
mRNA	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3538-3546	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

NOTES	NULL
6219	NULL
.	NULL

Niederman	NULL
,	NULL
T.	NULL
M.	NULL
J.	NULL
,	NULL
B.	NULL
J.	NULL
Thiclan	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
negative	NULL
factor	NULL
is	NULL
a	NULL
transcriptional	NULL
silencer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1128-1132.	NULL
.	NULL

Obaru	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
E.	NULL
DeClue	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
amino-terminal	NULL
amino	NULL
acid	NULL
affects	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
HIV-1	NULL
Nef	NULL
protein	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

5:308-312	NULL
.	NULL

Piette	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
H.	NULL
Kryszke	NULL
,	NULL
and	NULL
M.	NULL
Yaniv	NULL
.	NULL

1985	NULL
.	NULL

Specific	NULL
interaction	NULL
of	NULL
cellular	NULL
factors	NULL
with	NULL
the	NULL
B	NULL
enhancer	NULL
of	NULL
polyoma	NULL
virus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:2675-2685.	NULL
.	NULL

Robert-Guroff	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Popovic	NULL
,	NULL
S.	NULL
Gartuer	NULL
,	NULL
P.	NULL
Markham	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Reitz	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
far-	NULL
,	NULL
rev-	NULL
,	NULL
and	NULL
nef-specific	NULL
transcripts	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infected	NULL
lymphocytes	NULL
and	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3391-3398	NULL
.	NULL

Schnittman	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
M.	NULL
C.	NULL
Psallidopoulos	NULL
,	NULL
H.	NULL
C.	NULL
Lane	NULL
,	NULL
L.	NULL
Thompson	NULL
,	NULL
M.	NULL
Baseler	NULL
,	NULL
F.	NULL
Massari	NULL
,	NULL
C.	NULL
H.	NULL
Fox	NULL
,	NULL
N.	NULL
P.	NULL
Salzman	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
reservoir	NULL
for	NULL
HIV-1	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
is	NULL
a	NULL
T	NULL
cell	NULL
that	NULL
maintains	NULL
expression	NULL
of	NULL
CD4	NULL
.	NULL

Science	NULL
245:305-308	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
C.	NULL
A.	NULL
Norris	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
,	NULL
and	NULL
G.	NULL
Crabtree	NULL
.	NULL

1986	NULL
.	NULL

Promoter	NULL
region	NULL
of	NULL
interleukin-2	NULL
gene	NULL
undergoes	NULL
chromatin	NULL
structure	NULL
changes	NULL
and	NULL
confers	NULL
inducibility	NULL
on	NULL
chloramphenicol	NULL
ace-tyltransferase	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:3042-3049	NULL
.	NULL

Terwilliger	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1986	NULL
.	NULL

Effects	NULL
of	NULL
mutations	NULL
within	NULL
the	NULL
3	NULL
'	NULL
orf	NULL
open	NULL
reading	NULL
frame	NULL
region	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
(	NULL
HTLV-III/LAV	NULL
)	NULL
on	NULL
replication	NULL
and	NULL
cytopathogenicity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

:754-760	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
L.	NULL
Wiskocil	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Stobo	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
role	NULL
of	NULL
T3	NULL
surface	NULL
molecules	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
two-stimulus	NULL
requirement	NULL
for	NULL
IL-2	NULL
production	NULL
reflects	NULL
events	NULL
occurring	NULL
at	NULL
a	NULL
pre-translational	NULL
level	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

133:123-128	NULL
.	NULL

Wildeman	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
P.	NULL
Sassone-Corsi	NULL
,	NULL
T.	NULL
Grundstrom	NULL
,	NULL
M.	NULL
Zenke	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1984	NULL
.	NULL

Stimulation	NULL
of	NULL
in	NULL
vitro	NULL
transcription	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
by	NULL
the	NULL
enhancer	NULL
involves	NULL
a	NULL
specific	NULL
trans-acting	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

3:3129-3133.	NULL
.	NULL

Zagury	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Bernard	NULL
,	NULL
R.	NULL
Leonard	NULL
,	NULL
R.	NULL
Cheynier	NULL
,	NULL
M.	NULL
Feldman	NULL
,	NULL
P.	NULL
S.	NULL
Sarin	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1986	NULL
.	NULL

Long-term	NULL
cultures	NULL
of	NULL
HTLV-IIl-infected	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
model	NULL
of	NULL
cytopathology	NULL
of	NULL
T-cell	NULL
depletion	NULL
in	NULL
AIDS	NULL
.	NULL

Science	NULL
231:850-853	NULL
.	NULL

